<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Bramble: Mifepristone</title>
    <link>https://news.ketelle.co.uk/entities/mifepristone</link>
    <description>Stories involving Mifepristone, told neutrally, with how each side covers them.</description>
    <language>en-gb</language>
    <atom:link href="https://news.ketelle.co.uk/entities/mifepristone/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>FDA tells Louisiana court mifepristone safety review will finish by March 2027</title>
      <link>https://news.ketelle.co.uk/stories/fda-says-it-will-complete-mifepristone-safety-review-in-march-tells-lo</link>
      <guid isPermaLink="true">https://news.ketelle.co.uk/stories/fda-says-it-will-complete-mifepristone-safety-review-in-march-tells-lo</guid>
      <pubDate>Thu, 08 Oct 2026 11:50:30 +0100</pubDate>
      <category>Health</category>
      <description>In a court-ordered update filed Wednesday, the FDA said study results are due mid-December and a final report no later than March 2027. The review covers the abortion pill mifepristone, and the agency will then decide whether to change its rules. (2 outlets: 2 left · 0 centre · 0 right)</description>
      <media:content url="https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2026-10/261007-abortion-pill-vsb-2102-370e86.jpg" medium="image"/>
    </item>
  </channel>
</rss>
